Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pathology Inc.

Latest From Stada Arzneimittel AG

Commercial Capsules: Soriot, IPOs, Deals And Hemophilia Data

IPOs are up, hemophilia is driving company pipelines, speculation over Pascal Soriot's career plans drive billions from AstraZeneca's market capitalization, Sanofi signs a $650m vaccine deal, private equity bidders up their offer for Stada and earnings season kicks off. Commercial capsule rounds up recent business news and trends reported by sister publication Scrip.

Commercial Business Strategies

Deal Watch: Gilead And Spring Bank Set Second Trial Collaboration In HBV

Analyst speculates that Gilead could move to acquire Spring Bank if combo trial yields promising data for functional cure of hepatitis B. Eisai in-licenses PARP inhibitor with potential in breast cancer from Oncology Venture, while Sunovion out-licenses three corticosteroid products to Covis.

Deals Commercial

Deal Watch: Entasis, GARDP Partner On Novel Antibiotic For Drug-Resistant Gonorrhea

Servier and Transgene will collaborate to apply viral vector technology to the development of CAR-T therapeutics, while Chinese vaccine maker Sinovac is taken private by an investment consortium.

Deals M & A

Stada CEO & CFO Resign; Rumors Circle Of A New Takeover bid

Stada's top brass have quit following rumors earlier this week of a fresh takeover bid for the generic company from equity groups Bain and Cinven; ex-Boehringer executive Tjeenk Willink has been named incoming CEO.

M & A Appointments
See All

Company Information

  • Industry
  • In Vitro Diagnostics
    • Cytology
    • Molecular Diagnostics & Genetic Testing
  • Laboratory Testing Services
    • Anatomical Pathology
  • Services
  • Therapeutic Areas
  • Gynecological, Urological
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Pathology Inc.
  • Senior Management
  • Vicki DiFrancesco, Pres. & CEO
    Steve Pierce, CFO
    Alfred Lui, MD, Chmn. & CMO
    Ron Blum, SVP, Mktg. & Strategic Bus. Dev.
    Michael D Mosunic, VP, Sales
  • Contact Info
  • Pathology Inc.
    Phone: (310) 769-0561
    19951 Mariner Ave.
    Torrance, CA 90503